Biotechnology

Techseriesinsight > Blog > News > Biotechnology

June 3, 2026
PRNewswire
Biotechnology, News

AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026

Amgen today announced the presentation of new data across rare autoimmune and inflammatory diseases at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, taking place from June...

June 2, 2026
PRNewswire
Biotechnology, News

Phosphorex Names John Rigg Chairman of the Board

Phosphorex, a drug delivery-focused CDMO specializing in lipid nanoparticles, polymeric nanoparticles, and polymeric microspheres, has named John Rigg Chairman of its Board of Directors. Rigg joined the Phosphorex board...

June 1, 2026
PRNewswire
Biotechnology, News

Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that it has entered into a definitive agreement under which Servier, an independent international pharmaceutical group governed...

May 28, 2026
PRNewswire
Biotechnology, News

University of Chicago Urologist Performs First Commercial Vanquish® Water Vapor Ablation Procedures in the State

The procedure was performed on an outpatient basis at the Ingalls Memorial Ambulatory Surgical Center on a patient diagnosed with localized prostate cancer. Vanquish Water Vapor Ablation uses thermal...

May 27, 2026
PRNewswire
Biotechnology, News

CenExel highlights industry-leading capabilities amid growing FDA momentum advancing psychedelic clinical research

The FDA recently announced it is shifting regulatory attention and investment for emerging psychedelic-based therapeutics treating mental health conditions. CenExel Clinical Research is answering this push with expansion to support psychedelic...

May 25, 2026
PRNewswire
Biotechnology, News

CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies – Persistence Market Research

The global CGRP inhibitors market is expanding rapidly, expected to be valued at around US$ 6.5 billion in 2026 and projected to reach US$ 12.5 billion by 2033, with a CAGR...

May 22, 2026
PRNewswire
Biotechnology, News

Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that Caris, the Caris Precision Oncology Alliance® (Caris POA) and collaborators from more than 60...

May 21, 2026
PRNewswire
Biotechnology, News

Volta Labs launches automated library preparation solution for the Oxford Nanopore Ligation Sequencing Kit V14

Volta Labs, maker of the Callisto™ Sample Prep System, today announced the availability of its DNA Library Preparation Application for the Oxford Nanopore Technologies Ligation Sequencing Kit V14 (SQK-LSK114)....

May 20, 2026
Business Wire
Biotechnology, News

Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial at EuroPCR 2026

Jupiter Endovascular, Inc. today announced that the SPIRARE II pivotal trial evaluating the use of the company’s Vertex™ Pulmonary Embolectomy System in patients with acute, intermediate-risk pulmonary embolism (PE) met...

May 15, 2026
PRNewswire
Biotechnology, News

Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board

Atisama Therapeutics (formerly Rage Bio) (“Atisama” or the “Company”), an Australian clinical-stage biotechnology company developing novel splice-switching oligonucleotide (SSO) therapeutics for chronic inflammatory disease, today reported progress in the...